Showing 16-20 of 63 :
OM1 Launches Analytics to Deliver Mental Health & Immunology Insights on Prescriber Trends and Therapy Effectiveness

Business Wire May 24, 2023 Read the full press release>> OM1 now offers a complementary suite of easy-to-digest analytics that give a real-world, 360° view of trends in treatment behaviors and patient outcomes May 24, 2023 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, a leading real-world data, outcomes, and technology company with a focus on chronic[…]

Reduction in healthcare resource use through 24 months following sinus surgery with steroid-eluting implants in chronic rhinosinusitis patients with and without nasal polyps: a real-world study

Taylor & Francis Online April 6, 2023 Read the full manuscript >> Objective: To investigate the impact of steroid-eluting implants after endoscopic sinus surgery (ESS) on health care resource use (HCRU) in chronic rhinosinusitis patients with (CRSwNP) and without (CRSsNP) nasal polyps. Methods: This retrospective, observational cohort study using real-world evidence data included adult patients[…]

Dermatology Data Can Direct Policy Priorities, but Gaps Reflect Inequities of Care

American Journal of Managed Care Mar 17, 2023 Christina Mattina Read the Full Article >> Speakers at the American Academy of Dermatology 2023 Annual Meeting highlighted the potential of DataDerm to tell the story of dermatological care in the United States, but some also cautioned that the registry only reflects those who have access to[…]

RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity

Dermatology Times Mar 19, 2023 Kaitlyn Bader Read the Full Article >>   A poster presentation from AAD 2023 explored RAPID3 scores to evaluate patient-reported outcomes in routine clinical practice therapy decisions regarding PsA. There is a lack of evidence investigating the impact of patient-reported outcomes (PROs) monitoring in routine clinical practice, according to a[…]

Interview with OM1’s Jessica Paulus at SCOPE

Published on: March 9, 2023 Applied Clinical Trials Watch the Full Interview >> Key Learning Objectives: Challenges people encounter when working with RWD How can RWD help address gaps in care? How OM1 engages or supports health equity research using RWD